Denali Therapeutics (DNLI) EPS (2017 - 2026)
Denali Therapeutics (DNLI) EPS from Dec 31, 2017 to Mar 31, 2026. The TTM Denali Therapeutics (DNLI) EPS is -$3.35. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Denali Therapeutics (DNLI) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +6.41% |
| 3 Years TTM | +5.66% |
| All Time TTM | +34.10% |
Annual EPS change of Denali Therapeutics (DNLI)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.81 | -75.33% |
| 2025 | -$3.28 | +11.95% |
| 2024 | -$2.93 | +179.34% |
| 2023 | -$1.05 | -56.23% |
| 2022 | -$2.40 | +0.90% |
| 2021 | -$2.38 | -502.61% |
| 2020 | $0.59 | -128.73% |
| 2019 | -$2.05 | +436.62% |
| 2018 | -$0.38 | -62.02% |
| 2017 | -$1.01 | N/A |